Table 1.
Variable | Patients (n = 380)n (%)/Median (Range)/Mean (±SD) |
---|---|
Age (years) | 40 (1–79) |
Sex (male) | 244 (64·2) |
Symptom duration (weeks) | 4 (1–52) |
Distance from hospital (kilometres) | 580 (6–3200) |
Proceeded to receive treatment | 109 (28·7) |
ECOG PS at diagnosis | n = 373 |
0/1 | 289 (77·5) |
2 | 71 (19) |
3/4 | 13 (3·5) |
Haemoglobin (g/l) | 77 ± 23·4 |
White blood cell count (×109/l) | 16·3 (0·2–920) |
Platelet count (×109/l) | 36 (2–394) |
Cytogenetic Risk Group | n = 247 |
Favourable | 29 (11·8) |
t (8;21) | 24 |
inv (16); t (16;16) | 5 |
Intermediate | 173 (70) |
Adverse | 45 (18·2) |
monosomy 7 | 12 |
del 5q; t(6;9); t(9;22) (1 each) | 3 |
inv 3 | 2 |
Complex karyotype | 28 |
ECOG PS, Eastern Cooperative Oncology Group performance score; SD, standard deviation.